CAV1 and Sepsis: Most recently, Ren et al. observed a modulation of the Caveolin-1/eNOS pathway by pravastatin, resulting in higher expression of tight junctions and clinically ameliorating acute lung injury during sepsis by decreasing pulmonary microvascular permeability [15].